Biblio

Export 223 results:
Author [ Title(Desc)] Type Year
Filters: First Letter Of Title is E  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
E
Y. Luo, Lin, R., Yan, Y., Su, J., Lin, S., Ma, M., and Li, H., “Effects of Remote Expressive Arts Program in Older Adults with Mild Cognitive Impairment: A Randomized Controlled Trial.”, J Alzheimers Dis, vol. 91, no. 2, pp. 815-831, 2023.
V. Bloniecki, Aarsland, D., Blennow, K., Cummings, J., Falahati, F., Winblad, B., and Freund-Levi, Y., “Effects of Risperidone and Galantamine Treatment on Alzheimer's Disease Biomarker Levels in Cerebrospinal Fluid.”, J Alzheimers Dis, vol. 57, no. 2, pp. 387-393, 2017.
T. Fleiner, Leucht, S., Förstl, H., Zijlstra, W., and Haussermann, P., “Effects of Short-Term Exercise Interventions on Behavioral and Psychological Symptoms in Patients with Dementia: A Systematic Review.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1583-1594, 2017.
T. A. Lansdell, Xu, H., Galligan, J. J., and Dorrance, A. M., “Effects of Striatal Amyloidosis on the Dopaminergic System and Behavior: A Comparative Study in Male and Female 5XFAD Mice.”, J Alzheimers Dis, vol. 94, no. 4, pp. 1361-1375, 2023.
N. Okamoto, Morikawa, M., Amano, N., Yanagi, M., Takasawa, S., and Kurumatani, N., “Effects of Tooth Loss and the Apolipoprotein E ɛ4 Allele on Mild Memory Impairment in the Fujiwara-kyo Study of Japan: A Nested Case-Control Study.”, J Alzheimers Dis, vol. 55, no. 2, pp. 575-583, 2017.
M. Okuya, Matsunaga, S., Ikuta, T., Kishi, T., and Iwata, N., “Efficacy, Acceptability, and Safety of Intravenous Immunoglobulin Administration for Mild-To-Moderate Alzheimer's Disease: A Systematic Review and Meta-Analysis.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1379-1387, 2018.
H. Florian, Meier, A., Gauthier, S., Lipschitz, S., Lin, Y., Tang, Q., Othman, A. A., Robieson, W. Z., and Gault, L. M., “Efficacy and Safety of ABT-126 in Subjects with Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors: A Randomized, Double-Blind, Placebo-Controlled Study.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1237-47, 2016.
F. Fan, Liu, H., Shi, X., Ai, Y., Liu, Q., and Cheng, Y., “The Efficacy and Safety of Alzheimer's Disease Therapies: An Updated Umbrella Review.”, J Alzheimers Dis, vol. 85, no. 3, pp. 1195-1204, 2022.
M. Tsolaki, Karathanasi, E., Lazarou, I., Dovas, K., Verykouki, E., Karacostas, A., Georgiadis, K., Tsolaki, A., Adam, K., Kompatsiaris, I., and Sinakos, Z., “Efficacy and Safety of Crocus sativus L. in Patients with Mild Cognitive Impairment: One Year Single-Blind Randomized, with Parallel Groups, Clinical Trial.”, J Alzheimers Dis, vol. 54, no. 1, pp. 129-33, 2016.
J. Jia, Wei, C., Jia, L., Tang, Y., Liang, J., Zhou, A., Li, F., Shi, L., and Doody, R. S., “Efficacy and Safety of Donepezil in Chinese Patients with Severe Alzheimer's Disease: A Randomized Controlled Trial.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1495-1504, 2017.
G. Liu, Weinger, J. G., Lu, Z. - L., Xue, F., and Sadeghpour, S., “Efficacy and Safety of MMFS-01, a Synapse Density Enhancer, for Treating Cognitive Impairment in Older Adults: A Randomized, Double-Blind, Placebo-Controlled Trial.”, J Alzheimers Dis, vol. 49, no. 4, pp. 971-90, 2016.
A. Saúde, Bouça-Machado, R., Leitão, M., Benedetti, A., and Ferreira, J. J., “The Efficacy and Safety of Physiotherapy in People with Dementia: A Systematic Review.”, J Alzheimers Dis, vol. 94, no. 3, pp. 909-917, 2023.
M. Boada, Anaya, F., Ortiz, P., Olazarán, J., Shua-Haim, J. R., Obisesan, T. O., Hernandez, I., Muñoz, J., Buendia, M., Alegret, M., Lafuente, A., Tárraga, L., Núñez, L., Torres, M., Grifols, J. Ramon, Ferrer, I., Lopez, O. L., and Páez, A., “Efficacy and Safety of Plasma Exchange with 5% Albumin to Modify Cerebrospinal Fluid and Plasma Amyloid-β Concentrations and Cognition Outcomes in Alzheimer's Disease Patients: A Multicenter, Randomized, Controlled Clinical Trial.”, J Alzheimers Dis, vol. 56, no. 1, pp. 129-143, 2017.
A. Homma, Atarashi, H., Kubota, N., Nakai, K., and Takase, T., “Efficacy and Safety of Sustained Release Donepezil High Dose versus Immediate Release Donepezil Standard Dose in Japanese Patients with Severe Alzheimer's Disease: A Randomized, Double-Blind Trial.”, J Alzheimers Dis, vol. 52, no. 1, pp. 345-57, 2016.
V. Orgeta, Tabet, N., Nilforooshan, R., and Howard, R., “Efficacy of Antidepressants for Depression in Alzheimer's Disease: Systematic Review and Meta-Analysis.”, J Alzheimers Dis, vol. 58, no. 3, pp. 725-733, 2017.
A. J García-Casal, Goñi-Imizcoz, M., M Perea-Bartolomé, V., Soto-Pérez, F., Smith, S. Jane, Calvo-Simal, S., and Franco-Martín, M., “The Efficacy of Emotion Recognition Rehabilitation for People with Alzheimer's Disease.”, J Alzheimers Dis, vol. 57, no. 3, pp. 937-951, 2017.
M. - F. Nguyen, Bonnefoy, M., Adrait, A., Gueugnon, M., Petitot, C., Collet, L., Roux, A., and Perrot, X., “Efficacy of Hearing Aids on the Cognitive Status of Patients with Alzheimer's Disease and Hearing Loss: A Multicenter Controlled Randomized Trial.”, J Alzheimers Dis, vol. 58, no. 1, pp. 123-137, 2017.
J. María García-Alberca, Gris, E., de la Guía, P., Mendoza, S., and de la Rica, M. López, “Efficacy of Souvenaid® Combined with Acetylcholinesterase Inhibitors in the Treatment of Mild Alzheimer's Disease.”, J Alzheimers Dis, vol. 91, no. 4, pp. 1459-1469, 2023.
C. Tuena, Mancuso, V., Stramba-Badiale, C., Pedroli, E., Stramba-Badiale, M., Riva, G., and Repetto, C., “Egocentric and Allocentric Spatial Memory in Mild Cognitive Impairment with Real-World and Virtual Navigation Tasks: A Systematic Review.”, J Alzheimers Dis, vol. 79, no. 1, pp. 95-116, 2021.
S. Tu, Spiers, H. J., Hodges, J. R., Piguet, O., and Hornberger, M., “Egocentric versus Allocentric Spatial Memory in Behavioral Variant Frontotemporal Dementia and Alzheimer's Disease.”, J Alzheimers Dis, vol. 59, no. 3, pp. 883-892, 2017.
S. - M. Shim, Cheon, H. - S., Jo, C., Koh, Y. Ho, Song, J., and Jeon, J. - P., “Elevated Epstein-Barr Virus Antibody Level is Associated with Cognitive Decline in the Korean Elderly.”, J Alzheimers Dis, vol. 55, no. 1, pp. 293-301, 2017.
Y. Yoshino, Mori, T., Yoshida, T., Yamazaki, K., Ozaki, Y., Sao, T., Funahashi, Y., Iga, J. - I., and Ueno, S. - I., “Elevated mRNA Expression and Low Methylation of SNCA in Japanese Alzheimer's Disease Subjects.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1349-1357, 2016.
J. M. Riphagen, van Egroo, M., and Jacobs, H. I. L., “Elevated Norepinephrine Metabolism Gauges Alzheimer's Disease-Related Pathology and Memory Decline.”, J Alzheimers Dis, vol. 80, no. 2, pp. 521-526, 2021.
L. K. McEvoy, Bergstrom, J., Hagler, D. J., Wing, D., and Reas, E. T., “Elevated Pure Tone Thresholds Are Associated with Altered Microstructure in Cortical Areas Related to Auditory Processing and Attentional Allocation.”, J Alzheimers Dis, vol. 96, no. 3, pp. 1163-1172, 2023.
B. Xie, Xu, Y., Liu, Z., Liu, W., Jiang, L., Zhang, R., Cui, D., Zhang, Q., and Xu, S., “Elevation of Peripheral BDNF Promoter Methylation Predicts Conversion from Amnestic Mild Cognitive Impairment to Alzheimer's Disease: A 5-Year Longitudinal Study.”, J Alzheimers Dis, vol. 56, no. 1, pp. 391-401, 2017.

Pages